Cardinal Health, Inc.
CAH
Rang in aandelen
#409
Cardinal Health, Inc. operates as a global, integrated provider of healthcare... Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.
Aandeelprijs
$255.85
Marktkapitalisatie
$59.24B
Verandering (1 dag)
1.10%
Verandering (1 jaar)
62.68%
Land
US
Handel Cardinal Health, Inc. (CAH)
Categorie
Healthcare
Winst voor Cardinal Health, Inc. (CAH)
Winst in Jun 2026 TTM: $2.17B
Volgens de meest recente financiële verslagen van Cardinal Health, Inc. bedraagt de huidige winst van het bedrijf $2.17B. In 2024 behaalde het bedrijf een winst van $1.20B, een stijging ten opzichte van de winst van 2023, die $663.00M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Cardinal Health, Inc. van 2000 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2026 (TTM) | $2.17B | 3.47% |
| 2025 | $2.10B | 74.94% |
| 2024 | $1.20B | 81.15% |
| 2023 | $663.00M | -184.57% |
| 2022 | $-784.00M | -342.72% |
| 2021 | $323.00M | -108.56% |
| 2020 | $-3.77B | -315.42% |
| 2019 | $1.75B | -867.98% |
| 2018 | $-228.00M | -111.85% |
| 2017 | $1.92B | -15.47% |
| 2016 | $2.28B | 15.71% |
| 2015 | $1.97B | 9.40% |
| 2014 | $1.80B | 102.48% |
| 2013 | $888.00M | -47.70% |
| 2012 | $1.70B | 11.84% |
| 2011 | $1.52B | 25.31% |
| 2010 | $1.21B | -27.32% |
| 2009 | $1.67B | -14.50% |
| 2008 | $1.95B | 55.70% |
| 2007 | $1.25B | -31.75% |
| 2006 | $1.84B | 12.63% |
| 2005 | $1.63B | -27.21% |
| 2004 | $2.24B | 5.26% |
| 2003 | $2.13B | 25.00% |
| 2002 | $1.70B | 27.71% |
| 2001 | $1.33B | 23.60% |
| 2000 | $1.08B | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| $6.46B | 197.06% |
US
|
|
| - | - |
US
|
|
| - | - |
US
|
|
| $708.86M | -67.39% |
AU
|
|
| $558.00M | -74.33% |
US
|
